SCHEMBL10142493

SCHEMBL10142493

Cc1c[nH]c2c1CCc1cnccc1-2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.36
CHRNA4 P43681 1/20 0.36
CCNC P24863 3/20 0.35
CDK8 P49336 3/20 0.35
SIGMAR1 Q99720 1/20 0.35
MAPK10 P53779 1/20 0.34
RIPK1 Q13546 1/20 0.34
NPC1 O15118 1/20 0.33
CYP19A1 P11511 3/20 0.32
CYP11B1 P15538 3/20 0.32
CYP11B2 P19099 3/20 0.32
TDO2 P48775 1/20 0.32
CYP17A1 P05093 1/20 0.31
SIRT3 Q9NTG7 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
CDK19 Q9BWU1 1/20 0.31
DYRK1A Q13627 3/20 0.30
NFATC1 O95644 2/20 0.30
GSK3B P49841 1/20 0.30
ADRA2A P08913 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23649351 0.78 NPC1 (0.40) NPC1CYP19A1CYP11B1CYP11B2CYP17A1
SCHEMBL10142566 0.76 CHRNB2 (0.35) CHRNB2CHRNA4SIGMAR1MAPK10RIPK1
SCHEMBL3597400 0.76 KDM4C (0.38) CHRNB2CHRNA4CCNCCDK8NPC1
SCHEMBL3604129 0.75 SIRT3 (0.43) CCNCCDK8CYP11B2SIRT3TDP1
SCHEMBL3599880 0.75 KDM4E (0.42)
SCHEMBL3593351 0.75 MAP2K1 (0.46) CCNCCDK8CYP11B2
SCHEMBL10142489 0.74 CHRNB2 (0.41) CHRNB2CHRNA4SIGMAR1DYRK1ANFATC1
SCHEMBL28852434 0.73 PARP10 (0.44) CYP19A1CYP11B1CYP11B2
SCHEMBL15005679 0.73 ROCK2 (0.33) CHRNB2CHRNA4CCNCCDK8NPC1
SCHEMBL10142500 0.72 GCGR (0.39) CHRNB2CHRNA4SIGMAR1CYP19A1CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8207180-B2 Tricyclic indoles and (4,5-dihydro) indoles NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-06-26 US disclosed
US-20100075998-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2010-03-25 US disclosed
WO-2008065054-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2008-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075998-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES CDC7, CDK7, CDK17 CHRNB2 3708/4885CHRNA4 3010/4885CCNC 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.